Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Probiodrug patents

Patents where

Current Assignee

Name

Probiodrug

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7732162 Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases	Patent 7732162 was granted and assigned to Probiodrug on June, 2010 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	7732162	June 8, 2010
‌ US Patent 7368421 Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis	Patent 7368421 was granted and assigned to Probiodrug on May, 2008 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	7368421	May 6, 2008
‌ US Patent 7381537 Use of inhibitors of glutaminyl cyclases for treatment and prevention of disease	Patent 7381537 was granted and assigned to Probiodrug on June, 2008 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	7381537	June 3, 2008
‌ US Patent 7462599 Use of effectors of glutaminyl and glutamate cyclases	Patent 7462599 was granted and assigned to Probiodrug on December, 2008 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	7462599	December 9, 2008
‌ US Patent 9650362 Inhibitors	Patent 9650362 was granted and assigned to Probiodrug on May, 2017 by the United States Patent and Trademark Office.	Probiodrug	Probiodrug	United States Patent and Trademark Office	9650362	May 16, 2017
‌ US Patent 7741354 Inhibitors of glutaminyl cyclase	Patent 7741354 was granted and assigned to Probiodrug on June, 2010 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	7741354	June 22, 2010
‌ US Patent 8962860 Inhibitors of glutaminyl cyclase	Patent 8962860 was granted and assigned to Probiodrug on February, 2015 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	8962860	February 24, 2015
‌ US Patent 8741614 Crystal structure of isoglutaminyl cyclase	Patent 8741614 was granted and assigned to Probiodrug on June, 2014 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	8741614	June 3, 2014
‌ US Patent 9676843 Uses of antibodies directed against amyloid-β	Patent 9676843 was granted and assigned to Probiodrug on June, 2017 by the United States Patent and Trademark Office.	Probiodrug	Probiodrug	United States Patent and Trademark Office	9676843	June 13, 2017
‌ US Patent 9277737 Mouse models carrying a knock-out mutation of the QPCTL-gene	Patent 9277737 was granted and assigned to Probiodrug on March, 2016 by the United States Patent and Trademark Office.	Probiodrug	Probiodrug	United States Patent and Trademark Office	9277737	March 8, 2016
‌ US Patent 7371871 Inhibitors of glutaminyl cyclase	Patent 7371871 was granted and assigned to Probiodrug on May, 2008 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	7371871	May 13, 2008
‌ US Patent 9657089 Diagnostic antibody assay	Patent 9657089 was granted and assigned to Probiodrug on May, 2017 by the United States Patent and Trademark Office.	Probiodrug	Probiodrug	United States Patent and Trademark Office	9657089	May 23, 2017
‌ US Patent 8486940 Inhibitors	Patent 8486940 was granted and assigned to Probiodrug on July, 2013 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	8486940	July 16, 2013
‌ US Patent 7667044 Compounds for the treatment of neurological disorders	Patent 7667044 was granted and assigned to Probiodrug on February, 2010 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	7667044	February 23, 2010
‌ US Patent 8409837 Crystal structure of glutaminyl cyclase	Patent 8409837 was granted and assigned to Probiodrug on April, 2013 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	8409837	April 2, 2013
‌ US Patent 9512115 Inhibitors	Patent 9512115 was granted and assigned to Probiodrug on December, 2016 by the United States Patent and Trademark Office.	Probiodrug	Probiodrug	United States Patent and Trademark Office	9512115	December 6, 2016
‌ US Patent 8058405 Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides	Patent 8058405 was granted and assigned to Probiodrug on November, 2011 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	8058405	November 15, 2011
‌ US Patent 8685664 Use of inhibtors of glutaminyl cyclases for treatment and prevention of disease	Patent 8685664 was granted and assigned to Probiodrug on April, 2014 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	8685664	April 1, 2014
‌ US Patent 8420684 Inhibitors of glutaminyl cyclase	Patent 8420684 was granted and assigned to Probiodrug on April, 2013 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	8420684	April 16, 2013
‌ US Patent 7897633 Inhibitors of glutaminyl cyclase	Patent 7897633 was granted and assigned to Probiodrug on March, 2011 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	7897633	March 1, 2011
‌ US Patent 7655684 Inhibitors of glutaminyl cyclase	Patent 7655684 was granted and assigned to Probiodrug on February, 2010 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	7655684	February 2, 2010
‌ US Patent 7803810 Inhibitors	Patent 7803810 was granted and assigned to Probiodrug on September, 2010 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	7803810	September 28, 2010
‌ US Patent 8647834 Screening method for enzyme inhibitors	Patent 8647834 was granted and assigned to Probiodrug on February, 2014 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	8647834	February 11, 2014
‌ US Patent 8470781 Use of effectors of glutaminyl and glutamate cyclases	Patent 8470781 was granted and assigned to Probiodrug on June, 2013 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	8470781	June 25, 2013
‌ US Patent 7625939 Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase IV inhibitors	Patent 7625939 was granted and assigned to Probiodrug on December, 2009 by the United States Patent and Trademark Office.		Probiodrug	United States Patent and Trademark Office	7625939	December 1, 2009

Results per page:

67 results

0 selected

67 results

0 selected